REPORT ID 3182

Global Sustained Release Ocular Drug Delivery Systems Market Professional SurveyReport 2019

Publish Date
2019
Pages
118
Format
Electronic (PDF)

This report studies Sustained Release Ocular Drug Delivery Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    pSivida
    Allergan
    Icon Bioscience
    Ocular Therapeutix
    Neurotech Pharmaceuticals
    Santen Pharmaceutical
    Aciont Inc.
    Envisia Therapeutics
    GrayBug
    Innocore Pharmaceuticals
    OHR Pharmaceuticals
    PolyActiva
    TheraKine

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Liposome
    Microcapsules/Nanocapsules
    Microspheres/Nanosptheres
    Implants

By Application, the market can be split into
    Cataract
    Glaucoma
    Corneal Transplantation
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey  Report 2019
1 Industry Overview of Sustained Release Ocular Drug Delivery Systems
    1.1 Definition and Specifications of Sustained Release Ocular Drug Delivery Systems
        1.1.1 Definition of Sustained Release Ocular Drug Delivery Systems
        1.1.2 Specifications of Sustained Release Ocular Drug Delivery Systems
    1.2 Classification of Sustained Release Ocular Drug Delivery Systems
        1.2.1 Liposome
        1.2.2 Microcapsules/Nanocapsules
        1.2.3 Microspheres/Nanosptheres
        1.2.4 Implants
    1.3 Applications of Sustained Release Ocular Drug Delivery Systems
        1.3.1 Cataract
        1.3.2 Glaucoma
        1.3.3 Corneal Transplantation
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems
    2.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
    2.4 Industry Chain Structure of Sustained Release Ocular Drug Delivery Systems

3 Technical Data and Manufacturing Plants Analysis of Sustained Release Ocular Drug Delivery Systems
    3.1 Capacity and Commercial Production Date of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers  in 2018
    3.2 Manufacturing Plants Distribution of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers  in 2018
    3.3 R&D Status and Technology Source of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers  in 2018
    3.4 Raw Materials Sources Analysis of Global Sustained Release Ocular Drug Delivery Systems Major Manufacturers  in 2018

4 Global Sustained Release Ocular Drug Delivery Systems Overall Market Overview
    4.1  2014-2019E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1  2014-2019E Global Sustained Release Ocular Drug Delivery Systems Capacity and Growth Rate Analysis
        4.2.2 2016 Sustained Release Ocular Drug Delivery Systems Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1  2014-2019E Global Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate Analysis
        4.3.2 2016 Sustained Release Ocular Drug Delivery Systems Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1  2014-2019E Global Sustained Release Ocular Drug Delivery Systems Sales Price
        4.4.2 2016 Sustained Release Ocular Drug Delivery Systems Sales Price Analysis (Company Segment)

5 Sustained Release Ocular Drug Delivery Systems Regional Market Analysis
    5.1 North America Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Overview
        5.1.2 North America  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.1.4 North America 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
    5.2 China Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.2.1 China Sustained Release Ocular Drug Delivery Systems Market Overview
        5.2.2 China  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.2.4 China 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
    5.3 Europe Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.3.1 Europe Sustained Release Ocular Drug Delivery Systems Market Overview
        5.3.2 Europe  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.3.4 Europe 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
    5.4 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.4.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Overview
        5.4.2 Southeast Asia  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.4.4 Southeast Asia 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
    5.5 Japan Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.5.1 Japan Sustained Release Ocular Drug Delivery Systems Market Overview
        5.5.2 Japan  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.5.4 Japan 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis
    5.6 India Sustained Release Ocular Drug Delivery Systems Market Analysis
        5.6.1 India Sustained Release Ocular Drug Delivery Systems Market Overview
        5.6.2 India  2014-2019E Sustained Release Ocular Drug Delivery Systems Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales Price Analysis
        5.6.4 India 2016 Sustained Release Ocular Drug Delivery Systems Market Share Analysis

6 Global  2014-2019E Sustained Release Ocular Drug Delivery Systems Segment Market Analysis (by Type)
    6.1 Global  2014-2019E Sustained Release Ocular Drug Delivery Systems Sales by Type
    6.2 Different Types of Sustained Release Ocular Drug Delivery Systems Product Interview Price Analysis
    6.3 Different Types of Sustained Release Ocular Drug Delivery Systems Product Driving Factors Analysis
        6.3.1 Liposome of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        6.3.2 Microcapsules/Nanocapsules of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        6.3.3 Microspheres/Nanosptheres of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        6.3.4 Implants of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis

7 Global  2014-2019E Sustained Release Ocular Drug Delivery Systems Segment Market Analysis (by Application)
    7.1 Global  2014-2019E Sustained Release Ocular Drug Delivery Systems Consumption by Application
    7.2 Different Application of Sustained Release Ocular Drug Delivery Systems Product Interview Price Analysis
    7.3 Different Application of Sustained Release Ocular Drug Delivery Systems Product Driving Factors Analysis
        7.3.1 Cataract of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        7.3.2 Glaucoma of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        7.3.3 Corneal Transplantation of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis
        7.3.4 Others of Sustained Release Ocular Drug Delivery Systems Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Sustained Release Ocular Drug Delivery Systems
    8.1 pSivida
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 pSivida 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 pSivida 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.2 Allergan
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Allergan 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Allergan 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.3 Icon Bioscience
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Icon Bioscience 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Icon Bioscience 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.4 Ocular Therapeutix
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Ocular Therapeutix 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Ocular Therapeutix 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.5 Neurotech Pharmaceuticals
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Neurotech Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Neurotech Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.6 Santen Pharmaceutical
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Santen Pharmaceutical 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Santen Pharmaceutical 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.7 Aciont Inc.
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Aciont Inc. 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Aciont Inc. 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.8 Envisia Therapeutics
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Envisia Therapeutics 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Envisia Therapeutics 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.9 GrayBug
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 GrayBug 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 GrayBug 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.10 Innocore Pharmaceuticals
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Innocore Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Innocore Pharmaceuticals 2016 Sustained Release Ocular Drug Delivery Systems Business Region Distribution Analysis
    8.11 OHR Pharmaceuticals
    8.12 PolyActiva
    8.13 TheraKine

9 Development Trend of Analysis of Sustained Release Ocular Drug Delivery Systems Market
    9.1 Global Sustained Release Ocular Drug Delivery Systems Market Trend Analysis
        9.1.1 Global  2019-2025 Sustained Release Ocular Drug Delivery Systems Market Size (Volume and Value) Forecast
        9.1.2 Global  2019-2025 Sustained Release Ocular Drug Delivery Systems Sales Price Forecast
    9.2 Sustained Release Ocular Drug Delivery Systems Regional Market Trend
        9.2.1 North America  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
        9.2.2 China  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
        9.2.3 Europe  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
        9.2.4 Southeast Asia  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
        9.2.5 Japan  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
        9.2.6 India  2019-2025 Sustained Release Ocular Drug Delivery Systems Consumption Forecast
    9.3 Sustained Release Ocular Drug Delivery Systems Market Trend (Product Type)
    9.4 Sustained Release Ocular Drug Delivery Systems Market Trend (Application)

10 Sustained Release Ocular Drug Delivery Systems Marketing Type Analysis
    10.1 Sustained Release Ocular Drug Delivery Systems Regional Marketing Type Analysis
    10.2 Sustained Release Ocular Drug Delivery Systems International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Sustained Release Ocular Drug Delivery Systems by Region
    10.4 Sustained Release Ocular Drug Delivery Systems Supply Chain Analysis

11 Consumers Analysis of Sustained Release Ocular Drug Delivery Systems
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Sustained Release Ocular Drug Delivery Systems Market Professional Survey  Report 2019
    Methodology
    Analyst Introduction
    Data Source